NOT FOR DISTRIBUTION IN OR TO THE UNITED STATES (OR for the account or benefit of, U.S. Persons), CANADA, AUSTRALIA, SOUTH AFRICA, JAPAN OR IN ANY OTHER JURISDICTION IN WHICH, OR TO PERSONS IN ANY JURISDICTION TO WHOM, SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW 11 May 2021 Disposal of shares in NatWest Group plc for £ 1.1bn in total Further to its announcement on 10 May 2021, UKGI announces the successful completion of the disposal of part of HM Treasury s shareholding in NatWest Group plc (the Company ). The disposal was effected by way of a placing (the Placing ) of 580,000,000 ordinary shares with a nominal value of £1.00 each (the Placing
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Kellogg Company Announces Pricing of its Inaugural Sustainability Bond
May 11, 2021 GMT
Kellogg Company logo (PRNewsFoto/Kellogg Company)
BATTLE CREEK, Mich., May 11, 2021 /PRNewswire/ Kellogg Company (NYSE: K) today announced it has successfully priced a EUR 300 million 8-year Sustainability Bond with an interest coupon of 0.50% per annum, a first for the global food company. This milestone is aligned with Kellogg’s heritage and commitment to social responsibility.
“Kellogg has always been a purpose-driven organization – it’s in our DNA,” said Steve Cahillane, Kellogg’s Chairman and Chief Executive Officer. “Our founder, W.K. Kellogg, was an early conservationist, a leading philanthropist and an original wellbeing visionary. With this legacy, we’ve inherited his commitment.”
DGAP-News: APONTIS PHARMA AG / Key word(s): IPO
APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share
06.05.2021 / 20:09
The issuer is solely responsible for the content of this announcement.
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.
APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share
Total placement volume of EUR 101 million including over-allotment and upsize options
Search jobs 29-Apr-2021 APONTIS PHARMA AG sets price range for planned IPO between EUR 18.50 and EUR 24.50 per share
DGAP-News: APONTIS PHARMA AG / Key word(s): IPO
29.04.2021 / 08:30
The issuer is solely responsible for the content of this announcement.
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.
APONTIS PHARMA AG sets price range for planned IPO between EUR 18.50 and EUR 24.50 per share
Japan Financial Services Agency: Preparation For Permanent Cessation Of LIBOR mondovisione.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mondovisione.com Daily Mail and Mail on Sunday newspapers.